BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 14727010)

  • 1. Restoration of euthyroidism accelerates bone turnover in patients with subclinical hypothyroidism: a randomized controlled trial.
    Meier C; Beat M; Guglielmetti M; Christ-Crain M; Staub JJ; Kraenzlin M
    Osteoporos Int; 2004 Mar; 15(3):209-16. PubMed ID: 14727010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.
    Baqi L; Payer J; Killinger Z; Hruzikova P; Cierny D; Susienkova K; Langer P
    Endocr Regul; 2010 Apr; 44(2):57-63. PubMed ID: 20429634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.
    Guo CY; Weetman AP; Eastell R
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):301-7. PubMed ID: 9156039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The level of TSH appeared favourable in maintaining bone mineral density in postmenopausal women.
    Baqi L; Payer J; Killinger Z; Susienkova K; Jackuliak P; Cierny D; Langer P
    Endocr Regul; 2010 Jan; 44(1):9-15. PubMed ID: 20151763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined therapy with L-thyroxine and L-triiodothyronine compared to L-thyroxine alone in the treatment of primary hypothyroidism.
    Fadeyev VV; Morgunova TB; Melnichenko GA; Dedov II
    Hormones (Athens); 2010; 9(3):245-52. PubMed ID: 20688622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of levothyroxine replacement therapy on bone and mineral metabolism in patients with hypothyroidism].
    Chai R; Ye Z; Zhan Z; Liu W; Yu M; Liu Y
    Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):18-21. PubMed ID: 11798620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).
    Meier C; Staub JJ; Roth CB; Guglielmetti M; Kunz M; Miserez AR; Drewe J; Huber P; Herzog R; Müller B
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4860-6. PubMed ID: 11600554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
    Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA
    Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis: effects on bone mineral density and bone markers.
    Trovas GP; Lyritis GP; Galanos A; Raptou P; Constantelou E
    J Bone Miner Res; 2002 Mar; 17(3):521-7. PubMed ID: 11874243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease inhibitor-associated bone mineral density loss is related to hypothyroidism and related bone turnover acceleration.
    Kinai E; Gatanaga H; Mizushima D; Nishijima T; Aoki T; Genka I; Teruya K; Tsukada K; Kikuchi Y; Oka S
    J Infect Chemother; 2017 May; 23(5):259-264. PubMed ID: 28274549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
    Chaki O; Yoshikata I; Kikuchi R; Nakayama M; Uchiyama Y; Hirahara F; Gorai I
    J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of bone loss in pre- and post-menopausal women on L-thyroxine therapy for non-toxic goitre.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Astazi P; Caradonna P
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):529-35. PubMed ID: 9425392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
    Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density and metabolism in children with congenital hypothyroidism after prolonged L-thyroxine therapy.
    Leger J; Ruiz JC; Guibourdenche J; Kindermans C; Garabedian M; Czernichow P
    Acta Paediatr; 1997 Jul; 86(7):704-10. PubMed ID: 9240877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density response to estrogen replacement in frail elderly women: a randomized controlled trial.
    Villareal DT; Binder EF; Williams DB; Schechtman KB; Yarasheski KE; Kohrt WM
    JAMA; 2001 Aug; 286(7):815-20. PubMed ID: 11497535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mass, bone turnover and body composition in former hypothyroid patients receiving replacement therapy.
    Langdahl BL; Loft AG; Eriksen EF; Mosekilde L; Charles P
    Eur J Endocrinol; 1996 Jun; 134(6):702-9. PubMed ID: 8766939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of bone turnover to bone density and fractures.
    Melton LJ; Khosla S; Atkinson EJ; O'Fallon WM; Riggs BL
    J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.